Dr. Chung-Liang Shih
For decades, hepatitis C has posed a significant global public health challenge, with an estimated 58 million people living with chronic infection worldwide. While no vaccine is currently available, the disease is now curable through highly effective direct-acting antiviral (DAA) therapies, typically administered over 8–12 weeks. Recognizing this opportunity, the World Health Organization (WHO) launched the Glasgow Declaration on Viral Hepatitis in 2015, setting an ambitious target to eliminate viral…